Pharmacy Compounding Advisory Committee July 13, 2000

8/21/01


Click here to start


Table of Contents

Pharmacy Compounding Advisory Committee July 13, 2000

Transdermal Drug Delivery System (TDS)

TDS

Types of TDS

PPT Slide

Factors Considered: Products are demonstrably difficult to compound

Drug Delivery System

Drug Formulation and Consistency

Drug Formulation and Consistency

Drug Formulation and Consistency

Transdermal Drug Delivery System Biopharmaceutics Considerations

Bioavailability

Testing and Quality Assurance

Preliminary Findings Difficulties in compounding result from the following characteristics and requirements:

Preliminary Conclusion

Author: CDER User